ArticleHaematologica2018

To what extent can mathematical modeling inform the design of clinical trials? The example of safe dose reduction of tyrosine kinase inhibitors in responding patients with chronic myeloid leukemia.

Joshua T Schiffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.